Photoinduced Cuproptosis with Tumor-Specific for Metastasis-Inhibited Cancer Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Cuproptosis is a novel regulated cell death pathway with potential to enhance existing anticancer treatments.
• Challenges remain in controlling copper ion release and maximizing therapeutic effects specifically at tumor sites.

Purpose of the Study:

• To develop a novel method for controlling copper ion valence to induce photo-activated cuproptosis in tumor cells.
• To exploit the tumor microenvironment and copper ionophores for targeted cancer therapy.

Main Methods:

• Development of CJS-Cu nanoparticles (NPs) for controlled copper ion release.
• Utilizing a cascade reaction involving H2O2, photoirradiation, and superoxide radicals to modulate copper ion valence.
• Investigating the generation of reactive oxygen species (ROS) and their impact on cellular components.

Main Results:

• CJS-Cu NPs selectively induced cuproptosis in tumor cells via a photochemical cascade.
• Generated ROS led to glutathione depletion and iron-sulfur cluster protein damage, augmenting cuproptosis.
• Effective suppression of tumor growth and inhibition of lung metastasis was observed.

Conclusions:

• The study presents a novel photochemical strategy for manipulating cellular cuproptosis.
• CJS-Cu NPs demonstrate potential for targeted cancer therapy with reduced side effects.
• This approach offers new avenues for enhancing anticancer treatments through controlled cell death induction.